Dr Sartor postulated that blacks either have a more robust immune system or their tumors are more responsive to immunotherapy compared with whites.
Approximately 40%0f the patients in the study were African American.
Test improved the identification of African American men at risk for aggressive cancer missed by a prostate biopsy.
Summaries of four phase 3 prostate cancer clinical trials to provide patients with an overview of the purpose, possible benefits and risks for each.
Use Internet Explorer, Firefox or Safari browsers, DO not use Google Chrome browser)
Men with low-risk prostate cancer who are not emotionally well may ask doctors for a more aggressive treatment regimen when it may not be necessary, a study suggests...
Evidence suggest that having a family history of prostate cancer should not automatically exclude men from active surveillance consideration, although questions remain.